Moleculin Biotech Stock Overlap Studies Bollinger Bands

MBRX Stock  USD 2.73  0.10  3.53%   
Moleculin Biotech overlap studies tool provides the execution environment for running the Bollinger Bands study and other technical functions against Moleculin Biotech. Moleculin Biotech value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of overlap studies indicators. As with most other technical indicators, the Bollinger Bands study function is designed to identify and follow existing trends. Moleculin Biotech overlay technical analysis usually involve calculating upper and lower limits of price movements based on various statistical techniques. Please specify the following input to run this model: Time Period, Deviations up, Deviations down, and MA Type.

The output start index for this execution was two with a total number of output elements of fifty-nine. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Moleculin Biotech middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Moleculin Biotech. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Moleculin Biotech Technical Analysis Modules

Most technical analysis of Moleculin Biotech help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Moleculin from various momentum indicators to cycle indicators. When you analyze Moleculin charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Moleculin Biotech Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Moleculin Biotech. We use our internally-developed statistical techniques to arrive at the intrinsic value of Moleculin Biotech based on widely used predictive technical indicators. In general, we focus on analyzing Moleculin Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Moleculin Biotech's daily price indicators and compare them against related drivers, such as overlap studies and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Moleculin Biotech's intrinsic value. In addition to deriving basic predictive indicators for Moleculin Biotech, we also check how macroeconomic factors affect Moleculin Biotech price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2021 2022 2024 (projected)
Net Debt To EBITDA3.11.40.94
Intangibles To Total Assets0.130.190.45
Hype
Prediction
LowEstimatedHigh
0.132.688.27
Details
Intrinsic
Valuation
LowRealHigh
0.203.939.52
Details
Naive
Forecast
LowNextHigh
0.052.748.33
Details
2 Analysts
Consensus
LowTargetHigh
7.288.008.88
Details

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Moleculin Biotech in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Moleculin Biotech's short interest history, or implied volatility extrapolated from Moleculin Biotech options trading.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Entertainment Idea
Entertainment
Invested over 90 shares
Macroaxis Index Idea
Macroaxis Index
Invested few shares
Hedge Favorites Idea
Hedge Favorites
Invested over 60 shares
Banking Idea
Banking
Invested over 20 shares
Disruptive Technologies Idea
Disruptive Technologies
Invested few shares
Cash Cows Idea
Cash Cows
Invested few shares
Momentum Idea
Momentum
Invested over 50 shares
Macroaxis Picks Idea
Macroaxis Picks
Invested over 30 shares
Investor Favorites Idea
Investor Favorites
Invested over 60 shares

Additional Tools for Moleculin Stock Analysis

When running Moleculin Biotech's price analysis, check to measure Moleculin Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Moleculin Biotech is operating at the current time. Most of Moleculin Biotech's value examination focuses on studying past and present price action to predict the probability of Moleculin Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Moleculin Biotech's price. Additionally, you may evaluate how the addition of Moleculin Biotech to your portfolios can decrease your overall portfolio volatility.